Column 17. What Are the Side Effects of RAI Therapy and What Is Their Frequency?

  • Seigo Kinuya
  • Naoyuki Shigematsu
  • Yasushi Noguchi
  • Tatsuya Higashi


As side effects in the acute stage, digestive symptoms and radiation sialoadenitis occur at a high frequency, but they can be regulated by antiemetics and antiphlogistics. Some pathological lesions require attention in terms of nerve disorders due to radiation edema depending on their location. Temporary gonadal dysfunction and effects on bone marrow can occur. Secondary malignancy is not a concern for adult patients.


Acute Stage Lacrimal Gland Secondary Malignancy Applied Dose Remnant Thyroid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Mandel SJ, Mandel L (2003) Radioactive iodine and the salivary glands. Thyroid 13:265–271 (NR)PubMedCrossRefGoogle Scholar
  2. 2.
    Zettinig G, Hanselmayer G, Fueger BJ et al (2002) Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study. Eur J Nucl Med Mol Imaging 29:1428–1432 (RS)PubMedCrossRefGoogle Scholar
  3. 3.
    Cherk MH, Kalff V, Yap KS et al (2008) Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 69:957–962 (RS)CrossRefGoogle Scholar
  4. 4.
    Van Nostrand D, Neutze J, Atkins F (1986) Side effects of “rational dose” iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. J Nucl Med 27:1519–1527 (RS)PubMedGoogle Scholar
  5. 5.
    Luster M, Lippi F, Jarzab B et al (2005) rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Endocr Relat Cancer 12:49–64 (NR)PubMedCrossRefGoogle Scholar
  6. 6.
    Garsi JP, Schlumberger M, Rubino C et al (2008) Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies. J Nucl Med 49:845–852 (RS)PubMedCrossRefGoogle Scholar
  7. 7.
    Ceccarelli C, Bencivelli W, Morciano D et al (2001) 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study. J Clin Endocrinol Metab 86:3512–3515 (RS)PubMedCrossRefGoogle Scholar
  8. 8.
    Schlumberger M, De Vathaire F, Ceccarelli C et al (1996) Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 37:606–612 (RS)PubMedGoogle Scholar
  9. 9.
    Wichers M, Benz E, Palmedo H et al (2000) Testicular function after radioiodine therapy for thyroid carcinoma. Eur J Nucl Med 27:503–507 (RS)PubMedCrossRefGoogle Scholar
  10. 10.
    Mathonne M, Clavel M, Labrousse F et al (2009) Unusual fatal effect of radioiodine (I-131) therapy: a case report. World J Nucl Med 8:187–191 (CaseR)Google Scholar
  11. 11.
    Rubino C, de Vathaire F, Dottorini ME et al (2003) Second primary malignancies in thyroid cancer patients. Br J Cancer 89:1638–1644 (RS)PubMedCrossRefGoogle Scholar
  12. 12.
    Bhattacharyya N, Chien W (2006) Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma. Ann Otol Rhinol Laryngol 115:607–610 (RS)PubMedGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Seigo Kinuya
    • 1
  • Naoyuki Shigematsu
    • 2
  • Yasushi Noguchi
    • 3
  • Tatsuya Higashi
    • 4
  1. 1.Department of Nuclear Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health ScienceKanazawa UniversityKanazawaJapan
  2. 2.Department of RadiologyKeio University School of MedicineTokyoJapan
  3. 3.Department of RadiologyNoguchi Thyroid Clinic and Hospital FoundationBeppuJapan
  4. 4.Shiga Medical Center Research InstituteOtsu-shiJapan

Personalised recommendations